GoodRx Holdings GDRX: Tech‑Health Pivot Raises Valuation Warnings
GoodRx Holdings (GDRX) climbs 1.4% amid tech‑health partnerships—AI‑enhanced comms and policy influence—but still lags behind its 200‑day average, leaving investors wary of its price‑fundamentals.
3 minutes to read


